Cargando…
Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery
Autores principales: | de Bock, Martin I., Roy, Anirban, Cooper, Matthew N., Dart, Julie A., Berthold, Carolyn L., Retterath, Adam J., Freeman, Kate E., Grosman, Benyamin, Kurtz, Natalie, Kaufman, Fran, Jones, Timothy W., Davis, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613919/ https://www.ncbi.nlm.nih.gov/pubmed/26316630 http://dx.doi.org/10.2337/dc15-1047 |
Ejemplares similares
-
User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics
por: Chen, Natalie S., et al.
Publicado: (2021) -
Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp
por: Ly, Trang T., et al.
Publicado: (2016) -
Safety of Real-life Usage of Advanced Hybrid Closed-Loop System MiniMed 780G in Children With Type 1 Diabetes Younger Than 7 Years Old
por: Tornese, Gianluca, et al.
Publicado: (2023) -
Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015) -
Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes
por: Boyle, Karen D., et al.
Publicado: (2016)